CGT-1786

N/A

Report date: 2025/01/26 18:14:56
NME

Base Information

Drug NameCGT-1786
Drug Alias NameErbb2 inhibitors (Cogent Biosciences)CGT-1786
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsUterine NeoplasmsCentral Nervous System NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCogent Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCogent Biosciences Inc
Inactive CompaniesN/A
Active IndicationsUterine NeoplasmsCentral Nervous System NeoplasmsBreast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A